Todd W. Garner - Jan 3, 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Role: Executive Vice President & CFO
Signature: Sarah M. Oliker for Todd W. Garner by Power of Attorney
Stock symbol: CNMD
Transactions as of: Jan 3, 2022
Transactions value $: -$92,913
Form type: 4
Date filed: 1/5/2022, 04:03 PM
Previous filing: Oct 5, 2021
Next filing: Mar 3, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNMD	Common Stock	Options Exercise	$0	+2K		$0.00	2K	Jan 3, 2022	Direct
transaction	CNMD	Common Stock	Tax liability	-$92.9K	-637	-31.85%	$145.86	1.36K	Jan 3, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNMD	Rsus (restricted Stock Units)	Options Exercise	$0	-2K	-100%	$0.00^*	0	Jan 3, 2022	Common Stock	2K	$0.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.001 per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (25%) over a four year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018.

Content

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.001 per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (25%) over a four year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018.